However, copeptin lacks specificity and can be easily influenced by other stressors, so it is suggested to investigate if it is an independent indicator of the prognosis of ICH and whether it can be used in combination with other biomarkers to achieve an optimal prognostic value in stroke and other life-threatening acute conditions. This evidence concerns the gene AVP and stroke disorder.